2022 Q3 Form 10-Q Financial Statement

#000089467122000020 Filed on August 15, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $12.53M $11.22M $10.66M
YoY Change 11.63% 0.2% -4.22%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $687.0K $668.0K $667.0K
YoY Change -20.76% -32.11% -38.13%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $4.491M $2.353M $5.048M
YoY Change 24.75% -30.73% 18.72%
Income Tax $801.0K $354.0K $923.0K
% Of Pretax Income 17.84% 15.04% 18.28%
Net Earnings $3.690M $1.999M $4.125M
YoY Change 21.38% -30.13% 16.82%
Net Earnings / Revenue 29.44% 17.81% 38.71%
Basic Earnings Per Share $0.77 $0.42 $0.87
Diluted Earnings Per Share $773.3K $418.9K $866.4K
COMMON SHARES
Basic Shares Outstanding 4.772M 4.772M 4.772M
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $113.1M $94.09M $163.7M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $21.66M $20.74M $21.72M
YoY Change -1.55% -6.14% -2.62%
Goodwill $7.319M $7.319M
YoY Change
Intangibles $35.00K $44.00K
YoY Change
Long-Term Investments
YoY Change
Other Assets $7.654M $5.728M $435.0K
YoY Change 1813.5% 1332.0% -27.5%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $1.252B $1.254B $1.258B
YoY Change 0.57% 1.37% 2.69%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $22.94M $20.98M $19.72M
YoY Change 9.26% 6.49% 0.6%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due $530.0K $531.0K $1.031M
YoY Change -66.88% -66.81% -67.78%
Total Short-Term Liabilities $23.47M $21.51M $20.75M
YoY Change 3.87% 0.98% -9.0%
LONG-TERM LIABILITIES
Long-Term Debt $26.59M $10.11M $9.607M
YoY Change 195.39% 12.31% 13.02%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $26.59M $10.11M $9.607M
YoY Change 195.39% 12.31% 13.02%
TOTAL LIABILITIES
Total Short-Term Liabilities $23.47M $21.51M $20.75M
Total Long-Term Liabilities $26.59M $10.11M $9.607M
Total Liabilities $1.124B $1.121B $1.122B
YoY Change 1.76% 2.16% 3.14%
SHAREHOLDERS EQUITY
Retained Earnings $106.8M $104.1M
YoY Change
Common Stock $57.19M $57.19M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $16.67M $16.67M
YoY Change
Treasury Stock Shares $693.9K $693.9K
Shareholders Equity $128.6M $132.6M $136.6M
YoY Change
Total Liabilities & Shareholders Equity $1.252B $1.254B $1.258B
YoY Change 0.57% 1.37% 2.69%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income $3.690M $1.999M $4.125M
YoY Change 21.38% -30.13% 16.82%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $5.119M $2.547M $2.563M
YoY Change 27.66% -24.64% 271.45%
INVESTING ACTIVITIES
Capital Expenditures -$714.0K -$746.0K -$202.0K
YoY Change 78.5% 239.09% 12.22%
Acquisitions
YoY Change
Other Investing Activities $15.04M -$68.20M -$3.498M
YoY Change 612.84% 7.54% -488.67%
Cash From Investing Activities $14.33M -$68.95M -$3.700M
YoY Change 732.97% 8.34% -613.89%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -429.0K -3.227M 12.83M
YoY Change -110.44% -135.58% -65.06%
NET CHANGE
Cash From Operating Activities 5.119M 2.547M 2.563M
Cash From Investing Activities 14.33M -68.95M -3.700M
Cash From Financing Activities -429.0K -3.227M 12.83M
Net Change In Cash 19.02M -69.63M 11.69M
YoY Change 93.26% 36.02% -69.33%
FREE CASH FLOW
Cash From Operating Activities $5.119M $2.547M $2.563M
Capital Expenditures -$714.0K -$746.0K -$202.0K
Free Cash Flow $5.833M $3.293M $2.765M
YoY Change 32.27% -8.53% 217.82%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 us-gaap Loans Held For Sale Fair Value Disclosure
LoansHeldForSaleFairValueDisclosure
844000
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4771774
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4787446
CY2022Q2 us-gaap Federal Home Loan Bank Advances General Debt Obligations Disclosures Maximum Amount Available
FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable
100000000
ovbc Cash Management Advances Maturity Period
CashManagementAdvancesMaturityPeriod
P90D
CY2022Q2 us-gaap Federal Home Loan Bank Advances General Debt Obligations Disclosures Amount Of Available Unused Funds
FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresAmountOfAvailableUnusedFunds
100000000
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0000894671
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4766453
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4787446
CY2022Q2 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
1507000
CY2022Q2 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
297000
CY2022Q2 us-gaap Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
231000
us-gaap Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
287000
us-gaap Allowance For Loan And Lease Losses Write Offs
AllowanceForLoanAndLeaseLossesWriteOffs
0
CY2021Q2 us-gaap Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
-30000
us-gaap Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
60000
CY2021Q4 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
1993000
CY2021Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
10000
CY2021 us-gaap Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
10000
CY2021 us-gaap Allowance For Loan And Lease Losses Write Offs
AllowanceForLoanAndLeaseLossesWriteOffs
0
us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
0
CY2022Q2 us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
0
us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
0
CY2021Q2 us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
0

Files In Submission

Name View Source Status
0000894671-22-000020-index-headers.html Edgar Link pending
0000894671-22-000020-index.html Edgar Link pending
0000894671-22-000020.txt Edgar Link pending
0000894671-22-000020-xbrl.zip Edgar Link pending
exhibit311_063022.htm Edgar Link pending
exhibit312_063022.htm Edgar Link pending
exhibit32_063022.htm Edgar Link pending
exhibit41_063022.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
ovbc-20220630.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
ovbc-20220630_cal.xml Edgar Link unprocessable
ovbc-20220630_def.xml Edgar Link unprocessable
ovbc-20220630_lab.xml Edgar Link unprocessable
ovbc-20220630_pre.xml Edgar Link unprocessable
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sec10q063022.htm Edgar Link pending
Show.js Edgar Link pending
sec10q063022_htm.xml Edgar Link completed